author={K. Lim and J. R. Kim and J. W. Kim and B. H. Kim and E. T. Kim and S. Yoo and J. S. Kwon and J. Lee and J. M. Jung and J. Park and H. J. Koh and J. Huh and B. Ku and Y. M. Choi and H. B. Seo and J. Cho and K. S. Yu and I. Jang and S. G. Shin},
  journal={Clinical Pharmacology & Therapeutics},
YKP1358 is a novel D2 antagonist. We conducted a D2 receptor occupancy study with YKP1358 in healthy Korean male volunteers using PET, to measure the D2 occupancy and how it relates to plasma drug levels.